Please login to the form below

Not currently logged in
Email:
Password:

Westminster Advisers expands health practice

Sarah Gullo and Emily Cameron join public affairs specialist agency

London-based Westminster Advisers has expanded its health practice, WA Health, with the appointment of two new associate directors to its team.

Sarah Gullo joins the public affairs specialist agency from Verve Communications, where she had served as a senior communications consultant since 2013.

Gullo brings over a decade of experience in political campaigning and communications advisory roles from both Australia and the UK, which includes working with NHS trusts and leading media relations for reform agenda on behalf of the Queensland government.

Meanwhile, also moving to WA Health is Emily Cameron who previously worked in life sciences minister George Freeman's parliamentary office as chief of staff and communications lead.

Prior to this, Cameron served as Whizz-Kidz's public affairs and campaigns manager, and also brings experience from Hanover Communications, The Health Foundation, and Gorkana.

Dominic Church, managing director at Westminster Advisers, said: “I'm delighted to welcome Emily and Sarah to Westminster Advisers.

“We're already proud of our health offer, and these hires further highlight our capability and capacity to deliver across the spectrum in healthcare communications, with a real strength in depth of knowledge and experience across the consultancy team.”

11th July 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics